Strata Oncology Announces Publication of Study Validating Clinical Utility of Pan-tumor Predictive Biomarker for Checkpoint Inhibitor Immunotherapy Benefit
Strata Oncology, Inc., a next-generation precision oncology company enabling smarter and earlier cancer treatment, today…
Arboretum_JDFebruary 7, 2023
